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Complete Influenza Vaccination
Trends for Children Six to
Twenty-Three Months
Tammy A. Santibanez, PhD,a Lisa A. Grohskopf, MD,a Yusheng Zhai, MSPH,b Katherine E. Kahn, MPHb

OBJECTIVE: Prevention of influenza among infants and young children is a public health

abstract

priority because of their high risk for influenza-related complications. Depending on a
child’s age and previous influenza vaccination history, they are recommended to receive
either 1 dose or 2 doses of influenza vaccine to be considered fully vaccinated against
influenza for the season. We compared estimates of full (complete) influenza vaccination
coverage of children 6 to 23 months across 10 consecutive influenza seasons (2002–2012),
by race/ethnicity, age group, and by number of doses required to be fully vaccinated given
child’s vaccination history.
METHODS: National Immunization Survey data were used to estimate full influenza

vaccination status among children 6 to 23 months on the basis of provider report. Estimates
were computed by using Kaplan-Meier survival analysis methods.
RESULTS: Full influenza vaccination coverage among children 6 to 23 months increased

from 4.8% in the 2002–2003 influenza season to 44.7% in the 2011–2012 season. In all 10
influenza seasons studied, non-Hispanic black children and Hispanic children had lower
full influenza vaccination coverage than non-Hispanic white children. For all 10 influenza
seasons, full influenza vaccination coverage was higher among children requiring only 1
dose compared with those requiring 2 doses.
CONCLUSIONS: Less than half of children 6 to 23 months in the United States, and an even
a smaller percentage of Hispanic and non-Hispanic black children, are fully vaccinated
against influenza. More implementation of evidence-based strategies that increase the
percentage of children who are fully vaccinated is needed.
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WHAT’S KNOWN ON THIS SUBJECT: Inﬂuenza
vaccination coverage with ≥1 dose based on parental
report has been routinely assessed and reported
since 2009 in the United States at http://www.cdc.
gov/ﬂu/ﬂuvaxview, but full inﬂuenza vaccination
coverage (by parent or provider report) has not
been assessed since then.
WHAT THIS STUDY ADDS: This study reports the
percentage of children 6 to 23 months in the United
States who were fully vaccinated against inﬂuenza
during each of 10 consecutive inﬂuenza seasons
(2002–2003 through 2011–2012) by race/ethnicity
based on provider reported data.
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ARTICLE

Prevention of influenza among
infants and young children is a
public health priority because
of their high risk for influenzarelated complications. Before 2002,
recommendations for influenza
vaccination of children in the United
States focused on those with health
conditions that confer increased risk
of severe illness from influenza.1
Recommendations for the routine
annual influenza vaccination of all
children were first made in 2002,
when the Advisory Committee on
Immunization Practices (ACIP) voted
to encourage providers to vaccinate
all children aged 6 to 23 months,
regardless of medical conditions.2
In 2004, the ACIP explicitly
recommended vaccination for all
children 6 to 23 months.3 Later, in
2006, these recommendations were
expanded to include all children 6 to
59 months and in 2008 to include all
children 6 months to 18 years.4,5
Children 6 months through 8 years
who are influenza vaccine–naive
require 2 doses of vaccine for
optimal immune response.6,7 The
ACIP recommends that children
6 months through 8 years receive
either 1 dose or two doses spaced
at least 4 weeks apart, depending
on previous influenza vaccination
history. The recommendations for
determining the needed number of
doses required to be considered fully
vaccinated against influenza have
changed over time (Table 1). For the
2002–2003 through the 2006–2007
seasons, 2 doses were recommended
for children who had never
received an influenza vaccination
previously, otherwise 1 dose was
recommended. In the 2007–2008
season the recommendation for 2
doses expanded to include those
who should have received 2 doses
in the previous season but received
only 1 dose. The emergence of
the pandemic 2009 H1N1 virus
(H1N1pdm09) ahead of the 2009–
2010 influenza season led to the
development of the monovalent
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pandemic vaccine, and 2 influenza
vaccines were recommended during
2009–2010: the trivalent seasonal
influenza vaccination and the
pandemic influenza A(H1N1)pdm09
(pH1N1) monovalent vaccine.8 For
the 2010–2011 season, given the
relative antigenic novelty of the
p(H1N1) virus, the recommended
approach for determining the
number of doses needed for young
children was modified to consider
both previous exposure to seasonal
influenza vaccines and the pH1N1
vaccine.9 During subsequent seasons
up through the 2014–2015 season,
the procedure for determining
the number of doses needed
continued to consider receipt of
both seasonal influenza vaccine
and the receipt of H1N1pdm09containing vaccine (Table 1), with
some further variations depending
on whether vaccine viruses had
changed compared with the previous
season.10–13
Influenza vaccination coverage
with at least 1 dose based solely
on parental report (ie, no provider
verification) has been routinely
assessed and reported since 2009,
but full vaccination coverage has not
been assessed since then.19 Obtaining
full vaccination coverage measures
based on parental report is more
complicated because it requires the
parent to remember and report the
child’s lifetime history of influenza
vaccination. Before the 2009–2010
season, coverage with at least 1
dose and full coverage based solely
on provider-reported vaccination
histories had been assessed among
children 6 to 23 months, but these
reports were discontinued due
to lack of timeliness, that is, the
estimates for 1 season were not
available before the start of the next
season due to the extended time
needed to obtain provider-reported
vaccination data. Furthermore,
nationally representative providerreported data were not available for
all of the age groups recommended to

receive annual influenza vaccination
as the recommendations expanded
from children 6 to 23 months to all
children 6 months and older.
This study focuses on children 6 to
23 months because, among children,
this age group has the highest risk
of influenza-related complications,
they were the first group of children
for which a routine influenza
recommendation was made, and this
is an age group for which nationally
representative provider-reported
influenza vaccination histories are
available from survey data. The
aims of this study were to examine
the percentage of children 6 to 23
months who were fully vaccinated
against influenza during each of
10 consecutive influenza seasons,
by race/ethnicity, age group, and
number of doses required to be
fully vaccinated given the child’s
vaccination history. The estimates in
this report can serve as a benchmark
against which full vaccination
coverage based on the more timely
parental report can be compared
once these measures are developed
for all children 6 months through 8
years.

METHODS
Survey Description
Data from the 2003 through 2012
National Immunization Survey (NIS)
were analyzed. The NIS is an ongoing,
national, list-assisted randomdigit-dialed, land-line and cellular
telephone survey of households with
children 19 to 35 months.20 Cellular
telephones were added to the NIS
in 2011.21 The household telephone
survey is followed by a mailed
questionnaire, the Immunization
History Questionnaire, to all of the
immunization providers identified
during the telephone survey and
for which permission to contact
them was granted by the parent.
The influenza vaccination coverage
estimates in this report are based
only on the provider-reported
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TABLE1 Full Inﬂuenza Vaccination Recommendations and Number of Doses Needed to be Fully Vaccinated, National Immunization Survey (NIS), ProviderReport, United States, 2002–2003 Through 2011–2012 Inﬂuenza Seasons
Recommendationsa

Inﬂuenza
Season
2002–2003
2003–2004
2004–2005

2005–2006

2006–2007

2007–2008

2008–2009

2009–2010

2010–2011

2011–2012

“Among previously unvaccinated children aged <9 years, two doses administered >1 months apart are recommended for
satisfactory antibody responses.“2
“Among previously unvaccinated children aged <9 years, two doses administered >1 month apart are recommended for
satisfactory antibody responses.”14
“Among previously unvaccinated children aged <9 years, 2 doses administered >1 month apart are recommended for
satisfactory antibody responses. If possible, the second dose should be administered before December. If a child aged
<9 years receiving vaccine for the ﬁrst time does not receive a second dose of vaccine within the same season, only 1
dose of vaccine should be administered the following season. Two doses are not required at that time.”3
“Among previously unvaccinated children aged <9 years, 2 doses administered >1 month apart are recommended for
satisfactory antibody responses. If possible, the second dose should be administered before December. If a child aged
<9 years receiving vaccine for the ﬁrst time does not receive a second dose of vaccine within the same season, only 1
dose of vaccine should be administered the following season. Two doses are not required at that time.”15
“Among previously unvaccinated children aged 6 months–<9 years, 2 doses of inactivated vaccine administered >1
month apart are recommended for eliciting satisfactory antibody responses. If possible, the second dose should be
administered before the onset of inﬂuenza season. If a child aged 6 months–<9 years receiving inﬂuenza vaccine for
the ﬁrst time does not receive a second dose of vaccine within the same season, only 1 dose of vaccine should be
administered the following season. Two doses are not required at that time.”16
“ACIP recommends 2 vaccine doses for children aged 6 months–8 years who received an inﬂuenza vaccine (either TIV
or LAIV) for the ﬁrst time in the previous season but who did not receive the recommended second dose of vaccine
within the same season. ACIP recommendations are now harmonized with regard to this issue with those of AAP. This
recommendation represents a change from the 2006 recommendations, in which children aged 6 months–8 years who
received only 1 dose of vaccine in their ﬁrst year of vaccination were recommended to receive only a single dose in the
following season. ACIP does not recommend that a child receive inﬂuenza vaccine for the ﬁrst time in the spring with
the intent of providing a priming dose for the following season. Children recommended for vaccination who are in their
third or more year of being vaccinated and who received only 1 dose in each of their ﬁrst 2 years of being vaccinated
should continue receiving a single annual dose.”17
“All children aged 6 months–8 years who have not received vaccination against inﬂuenza previously should receive 2 doses
of vaccine the ﬁrst inﬂuenza season that they are vaccinated. The second dose should be administered 4 or more weeks
after the initial dose. For example, children aged 6 months–8 years who were vaccinated for the ﬁrst time during the
2007–08 inﬂuenza season but only received 1 dose during that season should receive 2 doses of the 2008–09 inﬂuenza
vaccine. All other children aged 6 months–8 years who have previously received 1 or more doses of inﬂuenza vaccine at
any time should receive 1 dose of the 2008–09 inﬂuenza vaccine. Children aged 6 months–8 years who only received a
single vaccination during a season before 2007–08 should receive 1 dose of the 2008–09 inﬂuenza vaccine.”18
“All children aged 6 months–8 years who have not received vaccination against inﬂuenza previously should receive 2
doses of vaccine the ﬁrst inﬂuenza season that they are vaccinated. The second dose should be administered 4 or more
weeks after the initial dose. When only 1 dose is administered to children aged 6 months–8 years during their ﬁrst year
of vaccination, 2 doses should be administered in the following season. However, 2 doses should only be administered
in the ﬁrst season of vaccination, or in the season that immediately follows if only 1 dose is administered in the ﬁrst
season. For example, children aged 6 months–8 years who were vaccinated for the ﬁrst time with the 2008–09 inﬂuenza
vaccine but received only 1 dose should receive 2 doses of the 2009–10 inﬂuenza vaccine. All other children aged 6
months–8 years who have previously received 1 or more doses of inﬂuenza vaccine at any time should receive 1 dose of
the 2009–10 inﬂuenza vaccine. Children aged 6 months–8 years who received only a single vaccination during a season
before 2007–08 should receive 1 dose of the 2009–10 inﬂuenza vaccine.”5
“All children aged 6 months–8 years who receive a seasonal inﬂuenza vaccine for the ﬁrst time should be administered 2
doses. Children aged 6 months–8 years who received a seasonal vaccine for the ﬁrst time during 2009–2010 but who
received only 1 dose should receive 2 doses, rather than 1, during 2010–2011. In addition, for the 2010–11 inﬂuenza
season, children aged 6 months–8 years who did not receive at least 1 dose of an inﬂuenza A (H1N1) 2009 monovalent
vaccine should receive 2 doses of a 2010–11 seasonal inﬂuenza vaccine, regardless of previous inﬂuenza vaccination
history. Children aged 6 months–8 years for whom the previous 2009–10 seasonal or inﬂuenza A (H1N1) 2009
monovalent vaccine history cannot be determined should receive 2 doses of a 2010–11 seasonal inﬂuenza vaccine.”9
“Vaccination providers should note that, in previous seasons, children aged 6 months through 8 years who received only
1 dose of inﬂuenza vaccine in their ﬁrst year of vaccination required 2 doses the following season. However, because
the 2011–12 vaccine strains are unchanged from the 2010–11 season, children in this age group who received at least
1 dose of the 2010–11 seasonal vaccine will require only 1 dose of the 2011–12 vaccine. Children in this age group who
did not receive at least 1 dose of the 2010–11 seasonal inﬂuenza vaccine, or for whom it is not certain whether the
2010–11 seasonal vaccine was received, should receive 2 doses of the 2011–12 seasonal inﬂuenza vaccine.”10

Children Who
Needed 2 Doses, %
± 95% CIb
99.2 ± 0.2
96.5 ± 0.4

92.0 ± 0.6

81.5 ± 0.8

81.0 ± 1.0

88.7 ± 0.6

87.6 ± 0.8

84.4 ± 0.8

90.3 ± 0.6

70.1 ± 1.2

CI, conﬁdence interval.
a Recommendations regarding which children required 2 doses versus 1 dose to be fully vaccinated against inﬂuenza, as published in the annual “Prevention and Control of Inﬂuenza:
Recommendations of the Advisory Committee on Immunization Practices (ACIP),” published in Morbidity and Mortality Weekly Report.
b Aged 6 to 23 months.
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vaccinations. Providers reported the
entire lifetime history of influenza
vaccination on the Immunization
History Questionnaire for every
influenza season for which the child
had received vaccination. Age was
defined based on age on November
1 of the influenza season under
study, with this study being limited
to children who were 6 to 23 months
on November 1, realizing that some
children would age out of this age
range during the influenza season,
but they and all of their vaccinations
were included. For each influenza
season, 2 full calendar years of NIS
data files were combined for analysis
of the influenza season beginning the
previous calendar year. For example,
to obtain estimates for the 2002–
2003 influenza season, the 2003 and
2004 NIS data files were combined.
This was necessary to obtain an equal
distribution of children throughout
the age range of 6 to 23 months.
The race/ethnicity variable used in
this study (Hispanic, non-Hispanic
white only, non-Hispanic black only,
non-Hispanic other or multiple race)
is based on parent report of the
child’s race and ethnicity; children of
Hispanic ethnicity may be of any race.
The household response rates for the
NIS data included in this study, as
defined by the Council of American
Survey Research Organizations,
ranged from 61.6% to 73.1% for
the landline sample (2003–2012)
and 25.2% to 30.6% for the cellular
telephone sample (2011–2012).22
The percentage for which adequate
provider vaccination records were
obtained among children with
completed household interviews
ranged from 63.6% to 72.3%.22
Methodological details of the NIS
have been previously published.20

Statistical Methods
The Kaplan-Meier survival analysis
procedure was used to calculate
the percentage of children fully
vaccinated. The event variable was
defined as the provider-reported

4

month of the influenza vaccination
dose that made the child fully
vaccinated against influenza, either
the first (or only) dose or the second
dose. The number of doses needed
was determined on the basis of the
season-specific recommendations
for number of doses required, as
summarized in Table 1. The KaplanMeier method was also used to
calculate the percentage of children
who received at least 1 dose of
influenza vaccination (≥1 dose
coverage), with the event variable
defined as the provider-reported
month of the child’s first influenza
dose (regardless of their need for 1
or 2 doses). Influenza vaccinations
received during the entire influenza
season from July through May were
included in the coverage estimates.
This method was used to estimate
the percentage of children fully
vaccinated against influenza overall
and by age group, racial/ethnic
group, and number of doses required
to be fully vaccinated, and for the
2011–2012 season only, by state.
Differences between influenza
seasons within each group were
tested by using t tests. Likewise,
differences between groups within
each influenza season were tested
by using pairwise comparison t
tests. Comparisons reported as
being increases or decreases were
statistically significant, whereas
comparisons that were not
statistically significant are reported
as not being different. Reported
percentages and corresponding
95% confidence intervals were
weighted, and reported sample
sizes were unweighted. All analyses
were weighted to population totals,
unit nonresponse, and noncoverage
of nontelephone households and
to adjust for households having
multiple telephone lines. Tests for
linear trend were performed using
a weighted linear regression on
the season-specific estimates using
season number as the independent
variable and weights as the inverse

of the estimated variance of the
estimated vaccination coverage.
Pairwise comparisons of estimates
were conducted by using t tests
assuming large degrees of freedom
and used the value of 1.96 for
the critical value. Analyses were
conducted by using SAS release 9.3
(SAS Inc, Cary, NC) and SUDAAN
release 11.0.0 (Research Triangle
Institute, Research Triangle Park,
NC) statistical software to take into
account the complex survey design.
All statistical tests were 2-tailed
with the significance level set at α
< 0.05. Institutional review board
approval for conducting the NIS was
obtained through the National Center
for Health Statistics Research Ethics
Review Board and through the IRB of
NORC at the University of Chicago.

RESULTS
Percentage of Children Requiring 2
Doses
Among children 6 to 23 months, the
percentage of children requiring
2 doses to be considered fully
vaccinated varied by influenza season
as the dosage recommendations
changed (Table 1). The percentage of
children 6 to 23 months requiring 2
doses to be fully vaccinated against
influenza ranged from 70.1% for
2011–2012 to 99.2% for the 2002–
2003 season.

Trends in Full Inﬂuenza Vaccination
Coverage Overall
Full influenza vaccination coverage
among children 6 to 23 months
overall increased from the
2002–2003 influenza season to the
2011–2012 season (trend test P <
.001; Table 2; Fig 1). The average
annual increase was 4.2 percentage
points based on the slope of the
trend test. The estimates and annual
changes from the previous season
are denoted in Table 2. In only 2 of
the 10 influenza seasons (the 2007–
2008 and the 2010–2011 seasons),
there was no increase observed
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in the percentage of children fully
vaccinated compared with the
previous season. Full influenza
vaccination coverage by state for
the 2011–2012 influenza season
is presented in Table 3; coverage
ranged from 23.6% in Mississippi to
72.2% in Massachusetts.

Trends in Full Inﬂuenza Vaccination
Coverage by Age Group
Within each age group studied,
full influenza vaccination coverage
increased from the 2002–2003
influenza season to the 2011–2012
season (trend test P < .001 each;
Table 2). In 5 of the 10 influenza
seasons studied (2003–2004,
2004–2005, 2005–2006, 2006–2007,
and 2011–2012), there were no
differences between the age groups
in full influenza vaccination coverage.
In the remaining 5 seasons, children
aged 6 to 11 months had higher full
influenza vaccination coverage than
children in the older age groups.

Trends in Full Inﬂuenza Vaccination
Coverage by Race/Ethnicity
Within all 4 racial/ethnic groups
studied, full influenza vaccination
coverage increased from the
2002–2003 influenza season to the
2011–2012 season (trend test P
< .001 each; Table 2). The change
in vaccination coverage from one
season to the next within each group
is indicated in Table 2 including
whether these changes were
statistically significant.
In all 10 influenza seasons studied,
non-Hispanic black children
(hereafter referred to as black
children) and Hispanic children
had lower full influenza vaccination
coverage than non-Hispanic white
children (hereafter referred to as
white children; Table 2; Fig 2). The
gap in these racial/ethnic differences
does not appear to decrease in
magnitude over time. For example
the percentage of black children fully
vaccinated in the 2002–2003 season
was 2.7%, whereas the percentage of
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white children fully vaccinated was
6.1%, a difference of –3.4 percentage
points; for the remaining seasons
these black-white differences widen
as follows: –7.3, –10.3, –11.9, –12.5,
–13.7, –14.9, –14.2, –11.2, and –13.7
percentage points. The Hispanicwhite differences by season were as
follow: –3.4, –4.8, –8.2, –10.4, –8.6,
–8.9, –9.6, –7.7, –5.3, and –8.8). In
7 of the 10 seasons, black children
also had lower full influenza
vaccination coverage than Hispanic
children.
Similar racial/ethnic differences
were also seen among the estimates
of coverage with at least 1 dose of
influenza vaccination (Table 2).
In all 10 influenza seasons, black
children had lower ≥1 dose influenza
vaccination coverage than white
children. In 8 of the 10 seasons
Hispanic children had lower coverage
than white children, whereas in the
2009–2010 and 2010–2011 seasons
they had similar coverage.

Full Inﬂuenza Vaccination Coverage
by Number of Doses Required
Among children who required 1
dose to be fully vaccinated and
among those who required 2 doses,
full influenza vaccination coverage
increased from the 2002–2003
influenza season to the 2011–2012
season (trend test P < .001 each;
Table 2). The change in vaccination
coverage from one season to the next
within each group and whether these
changes were statistically significant
is indicated in Table 2. For all 10
influenza seasons, full influenza
vaccination coverage was higher
among children requiring only 1 dose
compared with those requiring 2
doses (Table 2). For the 2011–2012
season, among the subset of children
6 to 23 months who required
2 doses and received 1 dose, 63.7%
received their required second
dose, which can be viewed as the
completion rate among those who
began the series of 2 doses (not
shown in tables).

DISCUSSION
This study found that full influenza
vaccination coverage of children 6 to
23 months increased from 4.8% in
the 2002–2003 influenza season to
44.7% in the 2011–2012 season. This
is to be expected because previously
published reports of coverage with at
least 1 dose of influenza vaccination
have shown increases during this
time.19,23 Despite the increase, the
majority of children 6 to 23 months
in the United States were not fully
vaccinated against influenza.
Previous reports of full influenza
vaccination coverage of children 6 to
23 months have been published using
NIS provider-reported data, but these
reports used a different estimation
methodology (proportion estimate,
subset of children 6 to 23 months
during September–December and
only included vaccinations through
January).24–29 The estimates from
previous reports compared with the
estimates in this report are as follows
for the 2002–2003 season through
the 2009–2010 season: 4.4% versus
4.8%, 8.4% versus 9.1%, 17.8%
versus 19.2%, 20.6% versus 22.6%,
21.3% versus 26.1%, 23.4% versus
27.0%, 24.7% versus 31.4%, 30.1%
versus 34.4%, respectively.24–29
Note that the previous reports
slightly underestimated full
influenza vaccination coverage
as expected because they did not
count any vaccinations past January;
reanalyzing these data using the
improved Kaplan-Meir method
rather than the proportion estimate,
the censored nature of the data
could be taken into account and all
vaccinations counted. These reports
were discontinued due to lack of
timeliness of NIS provider-reported
influenza data (ie, the estimates
were not available before the start
of the next influenza season due to
the survey time needed to obtain
provider-reported vaccination
histories) and due to a need for
influenza vaccination estimates
for all children 6 months to 17
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10.4 ± 2.2ac

d. Other/multiple race, nonHispanic

36.3 ± 3.3bc
+12.3§

+13.6§

33.3 ± 2.2b
+17.3§
41.0 ± 1.3acd
+18.6§
30.1 ± 2.9bd
+16.5§

37.1 ± 1.0
+17.4§

24.0 ± 3.2ac

16.0 ± 1.7bd
+9.6§
22.4 ± 1.1ac
+13.1§
13.6 ± 2.5bd
+8.5§

19.7 ± 0.9
+11.6§

58.0 ± 3.5b
+3.7
15.9 ± 0.8a
+8.4§

+6.4§

+4.2§
54.3 ± 5.5b
+9.0
7.5 ± 0.6a
+3.1§

17.1 ± 2.3bc

15.1 ± 1.6b
+8.5§
23.3 ± 1.1acd
+11.9§
13.0 ± 2.1bd
+8.9§

19.8 ± 1.3
+10.4§
19.5 ± 1.4
+10.6§
18.1 ± 1.4
+9.0§

19.2 ± 0.8
+10.1‡

10.7 ± 2.5ac

6.6 ± 1.1bcd
+3.9§
11.4 ± 0.8ac
+5.3§
4.1 ± 1.3abd
+1.4

9.4 ± 1.1
+4.1§
8.9 ± 1.1
+4.2§
9.1 ± 1.0
+4.8§

9.1 ± 0.6
+4.3‡

% ± 95% CI,
Change

n = 26 181

2004–2005

+2.9

39.2 ± 3.5ac

31.3 ± 2.2bd
–2.0
40.6 ± 1.3ac
–0.4
30.3 ± 2.8bd
+0.2

36.6 ± 1.0
–0.5

52.8 ± 2.3b
–5.2§
15.7 ± 0.8a
–0.2

+6.3§

23.4 ± 2.6abc

16.9 ± 1.7bd
+1.8
27.3 ± 1.1acd
+4.0§
15.4 ± 2.1bd
+2.4

22.7 ± 1.6
+2.9§
22.6 ± 1.5
+3.1§
22.3 ± 1.3
+4.2§

22.6 ± 0.8
+3.4§

% ± 95% CI,
Change

n = 26 981

2005–2006
n = 21 991

+6.8§

46.0 ± 4.0ac

37.7 ± 2.6bcd
+6.4§
43.1 ± 1.4ac
+2.5§
31.8 ± 3.2abd
+1.5

40.4 ± 1.2
+3.8§

58.9 ± 2.7b
+6.1§
18.4 ± 1.0a
+2.7§

+4.1

27.5 ± 3.6ac

21.7 ± 2.2bcd
+4.8§
30.3 ± 1.3ac
+3.0§
17.8 ± 2.6abd
+2.4

25.8 ± 1.7
+3.1§
24.7 ± 1.8
+2.1
27.0 ± 1.8
+4.7§

26.1 ± 1.0
+3.5§

% ± 95% CI,
Change

+4.6

50.6 ± 3.7ac

42.7 ± 2.7bcd
+5.0§
48.0 ± 1.4ac
+4.9§
36.6 ± 3.1abd
+4.8§

45.3 ± 1.2
+4.9§

70.0 ± 3.2b
+11.1§
21.5 ± 1.0a
+3.1§

+2.5

30.0 ± 3.3ac

22.4 ± 2.2bcd
+0.7§
31.3 ± 1.3ac
+1.0
17.6 ± 2.4abd
–0.2

30.5 ± 1.8bc
+4.7§
26.0 ± 1.7a
+1.3
24.1 ± 1.6a
–2.9§

27.0 ± 1.0
+0.9

% ± 95% CI,
Change

n = 23 825

2007–2008

Inﬂuenza Season
2006–2007

+1.0

51.6 ± 4.0c

47.6 ± 2.7bc
+4.9§
52.9 ± 1.4ac
+4.9§
39.8 ± 3.1abd
+3.2

49.7 ± 1.2
+4.4§

72.7 ± 3.0b
+2.7
25.5 ± 1.1a
+4.0§

+3.7

33.7 ± 3.9ac

26.6 ± 2.4bcd
+4.2§
36.2 ± 1.3ac
+4.9§
21.3 ± 2.6abd
+3.7§

35.6 ± 1.9bc
+5.1§
30.4 ± 1.8a
+4.4§
27.9 ± 1.8a
+3.8§

31.4 ± 1.1
+4.4§

% ± 95% CI,
Change

n = 22 961

2008–2009

+7.8§

59.4 ± 3.9abc

54.3 ± 2.7cd
+6.7§
54.2 ± 1.4cd
+1.3
45.4 ± 3.2abd
+5.6§

53.6 ± 1.2
+3.9§

76.6 ± 2.5b
+3.9
26.5 ± 1.1a
+1.0

+5.5

39.2 ± 3.9ac

30.6 ± 2.5bcd
+4.0§
38.3 ± 1.4ac
+2.1§
24.1 ± 2.6abd
+2.8

36.0 ± 1.9b
+0.4
33.0 ± 1.9a
+2.6
34.0 ± 1.9
+6.1§

34.4 ± 1.1
+3.0§

% ± 95% CI,
Change

n = 23 747

2009–2010

+2.1

61.5 ± 3.6abc

56.6 ± 2.9cd
+2.3
56.7 ± 1.5cd
+2.5§
46.9 ± 3.4abd
+1.5

55.9 ± 1.2
+2.3§

81.7 ± 2.7b
+5.1§
28.4 ± 1.2a
+1.9§

–3.7

35.5 ± 3.7bc

31.5 ± 2.7bc
+0.9
36.8 ± 1.4acd
–1.5
25.6 ± 3.1abd
+1.5

41.9 ± 2.2bc
+5.9§
32.8 ± 2.0ac
–0.2
26.4 ± 1.7ab
–7.6§

33.7 ± 1.2
–0.7

% ± 95% CI,
Change

n = 23 098

2010–2011

+0.3

61.8 ± 4.0ac

55.6 ± 3.3bcd
–1.0
59.4 ± 1.6ac
+2.7§
50.5 ± 3.7abd
+3.6

57.5 ± 1.4
+1.6§

74.1 ± 2.4b
–7.6§
32.2 ± 1.5a
+3.8§

+13.2§

48.7 ± 4.2ac

40.2 ± 3.1bcd
+8.7§
49.0 ± 1.6ac
+12.2§
35.3 ± 3.5abd
+9.7§

45.4 ± 2.4
+3.5§
44.6 ± 2.4
+11.8§
43.9 ± 2.2
+17.5§

44.7 ± 1.3
+11.0§

% ± 95% CI,
Change

n = 19 490

2011–2012

5.9 ± 1.2

5.4 ± 1.0

6.0 ± 1.5

6.3 ± 1.1

6.0 ± 1.3

3.2 ± 0.4

3.8 ± 1.3

4.3 ± 0.6

3.3 ± 0.5

4.6 ± 0.8

4.0 ± 0.4

3.8 ± 0.9

4.1 ± 0.6

4.7 ± 0.5

4.2 ± 0.6

Slope ±
95% CI

Trend Test*

CI, conﬁdence interval half-width.
The presence or absence of superscripted letters denotes whether that estimate was statistically signiﬁcantly different at P < .05 from another row, and denotes which row it differed from (a, b, c, or d) based on pairwise comparison t tests. For

5.1 ± 1.2bd

6.4 ± 1.0bd

Race/ethnicity
a. Hispanic

c. Black only, non-Hispanic

8.1 ± 0.5

≥1 dose coverage
Overall

9.3 ± 0.6ac

4.4 ± 0.4a

b. Two

b. White only, non-Hispanic

45.3 ± 10.6b

6.5 ± 1.9ac

d. Other/multiple race, nonHispanic

Doses needed
a. One

2.7 ± 0.9bd

2.7 ± 0.6bd

Race/ethnicity
a. Hispanic

c. Black only, non-Hispanic

4.3 ± 0.6a

c. 17–23 mo

6.1 ± 0.5ac

4.7 ± 0.6

b. 12–16 mo

b. White only, non-Hispanic

5.3 ± 0.7c

4.8 ± 0.4

Age group
a. 6–11 mo

Full vaccination coverage
Overall

n = 25 316
% ± 95% CI,
Change†

n = 28 967

2003–2004

% ± 95% CI**

2002–2003

Report, United States, 2002–2003 Through 2011–2012 Inﬂuenza Seasons

TABLE 2 Full Inﬂuenza Vaccination Coverage Among Children Aged 6 to 23 Months by Inﬂuenza Season, Age Group, Racial/Ethnic Group, and Number of Doses Needed to Be Fully Vaccinated, NIS, Provider

example, in 2002–2003, the percentage of fully vaccinated 6- to 11-month-olds (a) was statistically signiﬁcantly different from the percentage of fully vaccinated 17- to 23-month-olds (c).
* Tests for linear trend were performed using a weighted linear regression on the season-speciﬁc estimates using season number as the independent variable and weights as the inverse of the estimated variance of the estimated vaccination
coverage. The estimated slope coefﬁcients were interpreted as the average change across seasons assuming a linear increase. Slopes and their 95% conﬁdence intervals are presented; all of the tests for linear trend were signiﬁcant at P < .001.
** Estimates obtained using Kaplan-Meier survival analysis methods.
† Change in percentage points compared with the previous inﬂuenza season.
‡ Pair-wise comparisons between adjacent inﬂuenza seasons were conducted using t tests; statistically signiﬁcant (P < .05) differences are footnoted.
Age on November ﬁrst of the inﬂuenza season under study.

TABLE 2 Continued
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FIGURE 1
Full inﬂuenza vaccination coverage among children aged 6 to 23 months by inﬂuenza season, NIS,
provider report, United States, 2002–2003 through 2011–2012 inﬂuenza seasons. aEstimates obtained
using Kaplan-Meier survival analysis methods and reported with 95% conﬁdence interval half-widths.

years. To address this, the NIS-Flu
was developed, which can provide
estimates of parental report of
influenza vaccination coverage for
children 6 months to 17 years for
an influenza season before the start
of the following influenza season.19
Parental report of at least 1 dose
of influenza vaccination has been
reported based on the NIS-Flu data;
however, parental report of full
vaccination coverage has not yet been
assessed. Full influenza vaccination
coverage of children 6 to 23 months
based on Immunization Information
Systems sentinel site data compared
with the national estimates from
this report likewise showed slight
differences: 35.9% versus 33.7%,
respectively, for the 2010–2011 season
and 44.3% versus 44.7%, respectively,
for the 2011–2012 season.30
NIS estimates based on provider
report are not as timely as estimates
based on parental report due to the
time needed to obtain vaccination
information from all immunization
providers. Additionally, for this study,
2 full calendar years of interviews
were used for each influenza season
to have a more equal age distribution
of children 6 months, 7 months, and
up to 23 months; if only 1 calendar

year was used, the sample would be
weighted more heavily toward older
children. Use of parental reported
influenza vaccination allows for
the timely production of influenza
vaccination coverage estimates.19
Obtaining parental report of full
influenza vaccination, however, is
more complicated because it requires
the parental report of several past
seasons of influenza vaccination,
which may be more subject to recall
bias. A thorough analysis of the
validity of parent- versus providerreported child influenza vaccination is
needed, including examining whether
there are differences by race/
ethnicity. Initial indications, when
examining the estimated number of
people vaccinated, are that parent
report overestimates influenza
vaccination coverage.19 At least 1
study did find differences in parental
versus provider report by various
sociodemographic characteristics,
including race/ethnicity.31 The ≥1
dose coverage estimates in this report,
based on provider report, are lower
than those based on the parentalreported NIS-Flu estimates; a detailed
validity study to quantify the extent of
parental overreporting is warranted.19

7

TABLE 3 Full Inﬂuenza Vaccination Coverage Among Children 6 to 23 Months by State, NIS, provider report, United States, 2011–2012 Inﬂuenza Season

Statea
Massachusetts
Connecticut
Rhode Island
Vermont
Delaware
Minnesota
New Hampshire
South Dakota
Hawaii
Wisconsin
Pennsylvania
Nebraska
North Dakota
Maine
New Jersey
District of Columbia
Missouri

Full Inﬂuenza
Vaccination % ±
95% CIb
72.2 ± 6.1
71.1 ± 6.4
65.3 ± 6.7
64.9 ± 6.1
64.5 ± 6.7
63.6 ± 6.9
62.7 ± 6.3
60.1 ± 6.8
57.7 ± 6.6
57.5 ± 6.6
56.7 ± 5.3
56.6 ± 6.4
56.2 ± 6.5
55.4 ± 6.8
55.2 ± 6.3
54.3 ± 7.1
51.6 ± 7.4

State
Colorado
New York
Arizona
New Mexico
Illinois
Washington
Michigan
Virginia
Ohio
North Carolina
Maryland
Oregon
California
Montana
Indiana
Idaho
Nevada

Full Inﬂuenza
Vaccination % ±
95% CIa
50.6 ± 7.2
50.4 ± 4.5
49.9 ± 7.0
48.2 ± 6.5
48.0 ± 4.7
47.8 ± 7.2
47.7 ± 7.0
47.6 ± 8.6
45.7 ± 6.6
44.1 ± 6.7
44.0 ± 7.0
43.7 ± 6.2
43.0 ± 6.8
42.1 ± 6.8
42.0 ± 6.7
41.6 ± 7.2
40.8 ± 6.2

State
Florida
Alaska
Kansas
Tennessee
Utah
Texas
Iowa
Kentucky
Louisiana
West Virginia
Georgia
Alabama
Wyoming
Oklahoma
South Carolina
Arkansas
Mississippi

Full Inﬂuenza
Vaccination % ± 95%
CIa
39.1 ± 7.1
38.9 ± 6.1
38.7 ± 6.2
38.6 ± 6.5
38.3 ± 6.4
36.7 ± 4.1
34.9 ± 6.9
34.5 ± 6.7
33.8 ± 6.3
33.5 ± 6.9
33.2 ± 7.0
32.9 ± 7.1
32.2 ± 6.7
31.8 ± 6.3
31.6 ± 6.3
26.6 ± 6.3
23.6 ± 6.3

CI, conﬁdence interval half-width.
a Ordered from highest to lowest full inﬂuenza vaccination coverage.
b Estimates obtained using Kaplan-Meier survival analysis methods.

FIGURE 2
Full inﬂuenza vaccination coverage among children aged 6 to 23 months by inﬂuenza season and
racial/ethnic group, NIS, provider report, United States, 2002–2003 through 2012–2013 inﬂuenza
seasons. aEstimates obtained using Kaplan-Meier survival analysis methods and reported with
conﬁdence interval half-widths. Estimates for the 2009–2010 season include only the seasonal
inﬂuenza vaccine and exclude the 2009 H1N1 vaccine. bStatistically signiﬁcant (P < .05) differences
between groups as well as the direction of the differences are as follows: 2002–2003: H < W; H < O; B <
W; B < O; 2003–2004: H < W; H < O; B < H; B < W; B < O. 2004–2005: H < W; B < W; O < W; B < O; 2005–2006:
H < W; H < O; B < W; B < O; O < W; 2006–2007: H<W; B < H; H < O; B < W; B < O; 2007–2008: H < W; B <
H; H < O; B < W; B < O; 2008–2009: H < W; B < H; H < O; B < W; B < O; 2009–2010: H < W; B < H; H < O;
B<W; B < O; 2011–2012: H < W; B < H; B < W; W < O; B < O; 2012–2013: H < W; B < H; H < O; B < W; B < O,
where H, Hispanic; W, white only, non-Hispanic; B, black only, non-Hispanic; O, other or multiple race,
non-Hispanic. All other pairwise comparisons not noted were not statistically signiﬁcant.
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Racial/ethnic differences in influenza
vaccination coverage among
adults have persisted over many
influenza seasons.32 The finding that
such differences also exist for full
influenza vaccination coverage of
young children is concerning. Broad
use of evidence-based strategies
that enhance access to vaccination
services, increase demand for
vaccinations, and use provider or
system interventions are important
components of efforts to increase
vaccination coverage and reduce
these differences.33 Furthermore,
providers are encouraged to begin
offering influenza vaccination soon
after vaccine becomes available
and to continue vaccination efforts
throughout the influenza season. This
is especially important for children
who require 2 doses within the
season to be fully protected.
This study is subject to at least
3 limitations. First, the NIS is a
telephone survey followed by a mail
survey to immunization providers.
Although statistical adjustments
compensate for nonresponse and

SANTIBANEZ et al

households without telephones,
bias might remain. Second, the
NIS relies on provider reported
vaccination histories; incomplete
records and reporting might affect
estimates. However, a previous
study has shown that nearly all
(97%) vaccinated children aged 6 to
23 months received their influenza
vaccination at a medical place (74%
at a doctor’s office, 18% at a clinic or
health center, and 5% at a hospital
or emergency department).30
Third, there was a change in the
NIS sampling design from landline

to dual frame (landline and cellular
telephone), which should be taken
into account when interpreting
trends over time in NIS estimates.

to increase the percentage of children
who are fully vaccinated. Prevention
of influenza among infants and
young children is a public health
priority because of their high risk for
influenza-related complications.

CONCLUSIONS
Less than half of children aged 6 to 23
months in the United States are fully
vaccinated against influenza, and
even a smaller percentage of Hispanic
and non-Hispanic black children.
Appropriate implementation of
evidence-based strategies is needed
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